Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program

In this episode, Dr. Valentin Fuster discusses a pivotal study on inflammation's role in obesity-related heart failure with preserved ejection fraction, highlighting findings from the STEP heart failure program. The research reveals that semaglutide improves heart failure symptoms and reduces inflammation across varying baseline CRP levels, suggesting cardiovascular benefits that extend beyond weight loss alone.

Episode metadata supplied by the publisher feed · Published Oct 14, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program

0:00 9:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JACC This Week?

This episode is 9 minutes long.

When was this JACC This Week episode published?

This episode was published on October 14, 2024.

Can I download this JACC This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!